Maxim Group Initiates Coverage On OS Therapies With Buy Rating, Announces Price Target of $8
'It's A Problem': VanEck CEO Sounds Off On US Budget Deficits, Rapid Change
Malaysia Morning Wrap | Hibiscus Petroleum Faces Sharp Decline in Profits Due to Asset Shutdowns and Market Conditions
Indivior Data Shows Rapid Initiation With Once-Monthly SUBLOCADE Significantly Improves Retention In Opioid Use Disorder Patients, Especially Among Fentanyl-Positive Participants; Study Also Administered Second SUBLOCADE Injection A Week Later Vs....
Cardiol Therapeutics' Presents Phase II MAvERIC-Pilot Clinical Results In Recurrent Pericarditis Presented At The AHA Scientific Sessions 2024; Marked And Rapid Reductions In Both Pericarditis Pain And Inflammation Maintained Throughout The 26-Week Study
Reported Sunday, Alnylam Reported Interim Phase 1 Results For Nucresiran (ALN-TTRsc04), Demonstrating Rapid And Sustained TTR Reduction Lasting Six Months After A Single Dose